Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion type Assertion NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_head.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion description "[XRCC3 241 MetMet is an independent determinant of favorable survival in NSCLC patients treated with cisplatin/gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_provenance.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion evidence source_evidence_literature NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_provenance.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion SIO_000772 16407418 NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_provenance.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion wasDerivedFrom befree-2016 NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_provenance.
- NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_assertion wasGeneratedBy ECO_0000203 NP530619.RA1KHF_aSt4ni40DAo39Fri9jAktpgysdyhS17PdJlUTY130_provenance.